Nanoparticle delivery of recombinant IL-2 (BALLkine-2) achieves durable tumor control with less systemic adverse effects in cancer immunotherapy
- Biomaterials, Available online 19 November 2021, 121257 | https://doi.org/10.1016/j.biomaterials.2021.121257